Jatoi Ismail
Department of Surgery, National Naval Medical Center, and the Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, USA.
Int J Fertil Womens Med. 2004 Sep-Oct;49(5):215-21.
In patients with primary breast cancer, the sentinel lymph node biopsy (SLNB) is a minimally invasive method of assessing nodal status, with the aim of reducing the morbidity of axillary lymph node dissection (ALND). The SLNB technique is relatively new, and there are several ongoing clinical trials to assess its long-term effects on survival, local recurrence, and morbidity. Yet, surgeons throughout the United States have already adopted it into their practices, and it is now widely used in the management of patients with primary breast cancer. In this article, we discuss some of the pertinent issues pertaining to the application of SLNB in the management of breast cancer.
在原发性乳腺癌患者中，前哨淋巴结活检（SLNB）是一种评估淋巴结状态的微创方法，目的是降低腋窝淋巴结清扫术（ALND）的发病率。SLNB技术相对较新，目前有几项正在进行的临床试验，以评估其对生存、局部复发和发病率的长期影响。然而，美国各地的外科医生已经将其应用于临床实践，现在它已广泛用于原发性乳腺癌患者的治疗。在本文中，我们讨论了与SLNB在乳腺癌治疗中的应用相关的一些问题。
